
("
Grant of performance share awards to PDMRs under Long Term Incentive Plan
PDMR |
Position/Status |
Maximum Number of Ordinary Shares under Awards |
|
CEO |
4,608,000 |
|
CFO |
3,392,000 |
Key Terms of the Awards
The terms of the Awards are consistent with those set out in the Director's Remuneration Policy of the Company, as amended pursuant to the passing of a shareholder resolution at its General Meeting of
The Awards will vest three years from grant, subject to the meeting of a share price performance condition covering the three years from the grant date (the "Share Price Performance Period") and a cumulative adjusted EBITDA performance condition covering the three financial years ending on
25% of the Awards will vest subject to the average closing price per Ordinary Share over the final three months of the Share Price Performance Period being
The table below summarises the key features of the share price performance element of the Awards:
Share price |
CAGR over period 1 |
Market cap 2 |
Market cap increase |
Vesting level |
Total value to awardees |
Dilution 3 |
Awardees' share of value growth |
|
19.4% |
|
|
0% |
£ - |
0.0% |
0.0% |
|
21.8% |
|
|
25% |
|
1.2% |
2.7% |
|
28.6% |
|
|
44% |
|
2.2% |
4.0% |
|
34.8% |
|
|
63% |
|
3.0% |
5.0% |
|
40.4% |
|
|
81% |
|
3.9% |
6.0% |
|
45.6% |
|
|
100% |
|
4.8% |
6.9% |
|
53.5% |
|
|
100% |
|
4.8% |
6.5% |
1 Compound Annual Growth Rate (CAGR) from
2 Market capitalisation calculated by reference to the Company's Issued Ordinary Share Capital as at
3 Dilution is based on the Company's Issued Ordinary Share Capital as at
The Awards will be subject to a two-year post vesting holding period, malus and clawback provisions, an overriding Remuneration Committee discretion to vary vesting levels from formulaic outcome to ensure values reflect underlying performance, the experience of shareholders and exceptional adverse events, and an overall value cap of
The Company will continue to operate within the standard
Enquiries:
+44 (0) 7385 024855
+44 (0) 207 183 1190
Panmure Liberum (Nominated Adviser and Broker)
Edward
+44 (0) 20 3100 2000
About
DEALING NOTIFICATION FORMS FOR USE BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY AND THEIR CLOSELY ASSOCIATED PERSONS
Notification Form
The
The information set out below is provided in accordance with the requirements of Regulation 19(3) of the EU Market Abuse Regulation No 596/2014:
1 |
Details of the person discharging managerial responsibilities/person closely associated |
|||||||
(a) |
|
1. 2.
|
||||||
2 |
Reason for the notification |
|||||||
(a) |
Position/status |
1. Chief Executive Officer 2. Chief Financial Officer
|
||||||
(b) |
Initial notification/Amendment |
Initial notification |
||||||
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||||
(a) |
|
The |
||||||
(b) |
LEI |
213800LZUQAYBHDEQY04 |
||||||
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||||
(a) |
Description of the financial instrument, type of instrument Identification code |
Ordinary shares of ISIN GB00BK71XP16 PEBB.L |
||||||
(b) |
Nature of the transaction |
Award of nil-cost option share awards pursuant to |
||||||
(c) |
Price(s) and volume(s) |
|
||||||
(d) |
Aggregated information - Aggregated volume - Price |
N/A |
||||||
(e) |
Date of the transaction |
|
||||||
(f) |
Place of the transaction |
Outside a trading venue |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the